The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Reich Siegfried since 2007.
This trader's CIK number is 1351888.
At the time of last reporting, Reich Siegfried was the EVP & Chief Scientific Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX).
Also see all insider trading activities at Turning Point Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | TPTX | 0 | $0 | 397 | $14,411 | 0 | $0 |
2021 | TPTX | 0 | $0 | 35,550 | $3,786,643 | 35,550 | $1,823,004 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2008 | SGXP | 0 | $0 | 7,029 | $20,953 | 14,063 | $0 |
2007 | SGXP | 0 | $0 | 17,966 | $80,596 | 35,937 | $0 |
1. Turning Point Therapeutics, Inc. (TPTX)
2. Sgx Pharmaceuticals, Inc. (SGXP)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-02-09 | TPTX | Sale | 397 | 36.30 | 14,411 |
2021-03-04 | TPTX | Option Ex | 35,550 | 51.28 | 1,823,004 |
2021-03-04 | TPTX | Sale | 35,550 | 106.52 | 3,786,643 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2008-08-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2008-08-15 | SGXP | Sale | 781 | 2.98 | 2,327 |
2008-07-15 | SGXP | Sale | 781 | 3.06 | 2,385 |
2008-07-15 | SGXP | Option Ex | 1,563 | .00 | 0 |
2008-06-16 | SGXP | Option Ex | 1,562 | .00 | 0 |
2008-06-16 | SGXP | Sale | 781 | 1.65 | 1,288 |
2008-05-15 | SGXP | Sale | 781 | 1.45 | 1,132 |
2008-05-15 | SGXP | Option Ex | 1,563 | .00 | 0 |
2008-04-15 | SGXP | Sale | 781 | 1.19 | 929 |
2008-04-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2008-03-17 | SGXP | Option Ex | 1,563 | .00 | 0 |
2008-03-17 | SGXP | Sale | 781 | 4.01 | 3,131 |
2008-03-17 | SGXP | Option Ex | 1,563 | .00 | 0 |
2008-03-17 | SGXP | Sale | 781 | 4.01 | 3,131 |
2008-02-15 | SGXP | Sale | 781 | 4.05 | 3,163 |
2008-02-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2008-01-15 | SGXP | Option Ex | 1,563 | .00 | 0 |
2008-01-15 | SGXP | Sale | 781 | 4.44 | 3,467 |
2007-12-17 | SGXP | Option Ex | 1,562 | .00 | 0 |
2007-12-17 | SGXP | Sale | 781 | 4.75 | 3,709 |
2007-11-15 | SGXP | Option Ex | 1,563 | .00 | 0 |
2007-11-15 | SGXP | Sale | 781 | 5.10 | 3,983 |
2007-10-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2007-10-15 | SGXP | Sale | 781 | 6.42 | 5,014 |
2007-09-17 | SGXP | Sale | 781 | 6.20 | 4,842 |
2007-09-17 | SGXP | Option Ex | 1,563 | .00 | 0 |
2007-08-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2007-08-15 | SGXP | Sale | 781 | 6.42 | 5,017 |
2007-07-16 | SGXP | Sale | 781 | 6.05 | 4,725 |
2007-07-16 | SGXP | Option Ex | 1,563 | .00 | 0 |
2007-06-15 | SGXP | Sale | 781 | 5.15 | 4,019 |
2007-06-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2007-05-15 | SGXP | Option Ex | 1,563 | .00 | 0 |
2007-05-15 | SGXP | Sale | 781 | 5.18 | 4,049 |
2007-04-16 | SGXP | Option Ex | 1,562 | .00 | 0 |
2007-04-16 | SGXP | Sale | 781 | 5.02 | 3,922 |
2007-03-15 | SGXP | Sale | 781 | 5.53 | 4,318 |
2007-03-15 | SGXP | Option Ex | 1,563 | .00 | 0 |
2007-02-15 | SGXP | Option Ex | 1,562 | .00 | 0 |
2007-02-15 | SGXP | Sale | 781 | 5.36 | 4,186 |
2007-01-16 | SGXP | Option Ex | 18,750 | .00 | 0 |
2007-01-16 | SGXP | Sale | 9,375 | 3.50 | 32,812 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reich Siegfried (EVP & Chief Scientific Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.